Catholic Health Initiatives Colorado
Catholic Health Initiatives Colorado was paid $1.17M by Medicaid between May 2022 and Dec 2024, across 67 billing codes. Its largest line is 99283, emergency room visit (moderate) — 52% of everything it billed.
FORT MORGAN, CO 80701
Next to other General Acute Care Hospital providers in Colorado
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 5,593 | $378K | |
| 2023 | 10,046 | $500K | |
| 2024incomplete | 7,560 | $292K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 52% | 3,615 | 3,395 | $612K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 18% | 1,252 | 1,192 | $209K |
| 96361 | Intravenous infusion, hydration; each additional hour | 8.2% | 240 | 225 | $96K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 7.4% | 576 | 539 | $87K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 6.8% | 507 | 479 | $80K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.0% | 166 | 134 | $24K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 327 | 315 | $9K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 437 | 386 | $9K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 388 | 119 | $8K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 523 | 468 | $6K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 71 | 24 | $5K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 36 | 32 | $3K |
55 more codes
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 523 | $3K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,748 | $2K |
| 80053 | Comprehensive metabolic panel | <1% | 1,954 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 239 | $2K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 81 | $2K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 377 | $2K |
| 87081 | <1% | 255 | $2K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 16 | $1K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 112 | $1K |
| 36415 | Collection of venous blood by venipuncture | <1% | 773 | $1K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 111 | $793.66 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 498 | $745.12 |
| 80050 | General health panel | <1% | 52 | $505.95 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 54 | $454.00 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 103 | $378.55 |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 13 | $303.49 |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 226 | $285.26 |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 127 | $248.28 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 161 | $201.62 |
| 86780 | <1% | 28 | $137.34 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 29 | $113.60 |
| 86762 | <1% | 16 | $100.50 | |
| 82247 | <1% | 16 | $78.72 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 29 | $71.31 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 296 | $54.00 |
| 81001 | <1% | 468 | $50.96 | |
| 86850 | <1% | 13 | $43.49 | |
| 36416 | <1% | 17 | $39.78 | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 27 | $34.96 |
| 86803 | <1% | 16 | $31.68 | |
| 87807 | <1% | 16 | $27.62 | |
| 83605 | <1% | 62 | $24.87 | |
| 86900 | <1% | 13 | $21.79 | |
| 86901 | <1% | 13 | $10.90 | |
| 83690 | <1% | 137 | $5.00 | |
| 81003 | 0% | 16 | $0.00 | |
| 82248 | 0% | 104 | $0.00 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 0% | 251 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 46 | $0.00 |
| 85610 | 0% | 30 | $0.00 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 15 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 16 | $0.00 |
| 81025 | 0% | 25 | $0.00 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 14 | $0.00 |
| 80306 | 0% | 13 | $0.00 | |
| J3490 | Unclassified drugs | 0% | 4,531 | $0.00 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 71 | $0.00 |
| 71045 | Radiologic examination, chest; single view | 0% | 115 | $0.00 |
| 84484 | 0% | 53 | $0.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 64 | $0.00 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 15 | $0.00 |
| 87430 | 0% | 12 | $0.00 | |
| 85730 | 0% | 12 | $0.00 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 0% | 13 | $0.00 |
| 80048 | Basic metabolic panel (calcium, ionized) | 0% | 26 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Catholic Health Initiatives Colorado | Colorado Springs, CO | $25.26M |
| Catholic Health Initiatives Colorado | Pueblo, CO | $23.66M |
| Catholic Health Initiatives Colorado | Lakewood, CO | $8.91M |
| Catholic Health Initiatives Colorado | Canon City, CO | $8.35M |
| Catholic Health Iniatives Colorado | Westminster, CO | $7.55M |
| Catholic Health Initiatives Colorado | Canon City, CO | $6.39M |
| Catholic Health Initiatives Colorado | Durango, CO | $5.98M |
| Longmont United Hospital | Longmont, CO | $5.25M |
| Catholic Health Initiatives Colorado | Lakewood, CO | $4.40M |
| Commonspirit Kansas, INC. | Ulysses, KS | $2.77M |
| Commonspirit Kansas, INC. | Garden City, KS | $1.22M |
| Catholic Health Iniatives Colorado | Frisco, CO | $691K |
| ST. Vincent Infirmary Medical Center | Sherwood, AR | $469K |
| Commonspirit Kansas, INC. | Dodge City, KS | $267K |
| Catholic Health Initiatives Colorado | Pueblo, CO | $153K |
| Catholic Health Initiatives Colorado | Colorado Springs, CO | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.